Growth in the core business

The Group substantially boosted its sales, growing in its established segments. PCT and IXS led the way with sales growth of about 20% each. IXM expanded by 7.5%. High sales volumes and continual improvements in operational excellence brought PCT and IXM pronounced EBITDA earnings growth of almost 38% and 35%, respectively. Expenses for greater investment in new applications were reflected in the earnings of IXS and EBT. The strong order book of EBT affirms the effective growth strategy of this emerging segment.